4.7 Letter

Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery

Journal

ANNALS OF ONCOLOGY
Volume 19, Issue 9, Pages 1659-1661

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdn540

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available